AMGN•benzinga•May 17, 2024 at 06:11 AM

Reported Earlier, FDA Approves Amgen's IMDELLTRA (tarlatamab-dlle) The First And Only T-Cell Engager Therapy For The Treatment Of Extensive-Stage Small Cell Lung Cancer

No summary available.

Read the full article from the original source for complete details and context.

Article published on May 17, 2024 by benzinga